Sökning: L773:0179 1958 OR L773:1432 1262
> (2020-2024) >
Defunctioning stoma...
-
Sandén, GustavUmeå universitet,Kirurgi
(författare)
Defunctioning stoma before neoadjuvant treatment or resection of endoscopically obstructing rectal cancer
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
2023-01-26
-
Springer Nature,2023
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-204495
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-204495URI
-
https://doi.org/10.1007/s00384-023-04318-8DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Aim: To investigate whether patients with endoscopically untraversable rectal cancer may benefit from a defunctioning stoma created before neoadjuvant therapy or resectional surgery.Methods: This retrospective study comprise patients diagnosed with rectal cancer during 2007–2020 in Region Västerbotten, Sweden. The primary outcome was time between diagnosis and any treatment, while survival and the incidence of complications were secondary outcomes. Excluded were patients without endoscopic obstruction, patients already having a stoma, patients with recurrent disease, palliative patients, and patients receiving a stoma shortly after diagnosis due to any urgent bowel-related complication. Data were obtained from the Swedish Colorectal Cancer Registry and medical records. Kaplan–Meier failure curves were drawn, and a multivariable Cox regression model was employed for confounding adjustment.Results: Out of 843 patients, 57 remained after applying exclusion criteria. Some 12/57 (21%) patients received a planned stoma before treatment, and the remainder received upfront neoadjuvant therapy or surgery. Median time to any treatment was 51 days for the planned stoma group and 36 days for the control group, with an adjusted hazard ratio of 0.28 (95% confidence interval: 0.12–0.64). Complications occurred at a rate of 5/12 (42%) and 7/45 (16%) in the planned stoma group and control group, respectively. Survival was similar between groups.Conclusion: A planned stoma results in treatment delay, but it remains unclear whether this is clinically relevant. Complications were more common in the planned stoma group, although the data are limited. While larger studies are needed, it seems feasible to avoid defunctioning stomas even in endoscopically obstructing rectal cancers.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Svensson, Johan,1978-Umeå universitet,Statistik(Swepub:umu)josv0027
(författare)
-
Ljuslinder, Ingrid,1968-Umeå universitet,Onkologi(Swepub:umu)inlj0001
(författare)
-
Rutegård, Martin,1982-Umeå universitet,Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM),Institutionen för kirurgisk och perioperativ vetenskap(Swepub:umu)maru0039
(författare)
-
Umeå universitetKirurgi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:International Journal of Colorectal Disease: Springer Nature38:10179-19581432-1262
Internetlänk
Hitta via bibliotek
Till lärosätets databas